AMBUJACEM quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Ambuja Cements Ltd reported sales of ₹9,197 Cr, operating profit of ₹1,271 Cr (OPM 14%) and net profit of ₹236 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
AMBUJACEM quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
9,411
9,981
10,289
9,175
10,277
10,916
9,500
9,197
Expenses
7,700
8,113
8,328
7,413
8,924
9,451
7,911
7,926
Operating Profit
1,712
1,868
1,961
1,762
1,353
1,465
1,589
1,271
OPM
18%
19%
19%
19%
13%
13%
17%
14%
Other Income
1,355
713
300
38
77
136
150
-22
Interest
67
14
67
77
59
21
57
74
Depreciation
607
694
767
840
911
1,053
834
877
Profit before tax
2,393
1,872
1,427
883
460
527
848
298
Tax
-11%
28%
27%
-165%
12%
-252%
22%
21%
Net Profit
2,663
1,351
1,041
2,336
403
1,857
660
236
EPS in Rs
8.76
4.16
3.53
7.18
0.97
7.4
2.32
0.78
AMBUJACEM profit & loss, annual (₹ Cr)
Metric
Mar 2023
Mar 202315m
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
-
38,937
33,160
35,336
40,656
39,890
Expenses
-
33,815
26,760
29,366
34,079
34,212
Operating Profit
-
5,122
6,400
5,971
6,577
5,678
OPM
-
13%
19%
17%
16%
14%
Other Income
-
447
1,401
2,646
516
341
Interest
-
195
276
216
224
211
Depreciation
-
1,645
1,628
2,297
3,570
3,675
Profit before tax
-
3,729
5,896
6,104
3,299
2,133
Tax
-
19%
20%
13%
-71%
-
Net Profit
-
3,024
4,735
5,294
5,637
3,156
EPS in Rs
-
13.01
16.26
17.47
19.13
11.47
Dividend Payout
-
19%
12%
11%
10%
-
AMBUJACEM balance sheet (₹ Cr)
Metric
Mar 2023
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Equity Capital
397
440
493
-
494
Reserves
31,301
41,012
53,086
-
58,853
Borrowings
523
699
788
-
866
Other Liabilities
19,501
22,916
26,735
-
29,361
Total Liabilities
51,721
65,067
81,102
-
89,574
Fixed Assets
23,551
32,194
42,766
-
58,263
CWIP
2,526
2,658
9,858
-
9,121
Investments
214
849
1,912
-
113
Other Assets
25,430
29,365
26,566
-
22,077
Total Assets
51,721
65,067
81,102
-
89,574
AMBUJACEM cash flows (₹ Cr)
Metric
Dec 2021
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
5,309
735
5,646
2,237
5,362
Cash from Investing Activity
-2,007
-14,481
-8,941
-7,529
-7,935
Cash from Financing Activity
-516
2,931
5,689
5,592
-1,629
Net Cash Flow
2,786
-10,815
2,394
301
-4,203
Free Cash Flow
3,013
-3,331
1,685
-6,354
-594
CFO/OP
96%
29%
103%
44%
77%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit